Evidence map›Paper›PMID 36380543›Full record

ArticleInternational journal of surgery case reports2022

Progressive Acral Lentiginous Melanoma diagnosed via histopathology and surgically eradicated in a fingernail in a 69-year-old male - A Case Report.

Abrar Ismael, Mhd Imadaldin Alsamman, Omar Al Laham, Reham Albrijawy, Ayham Badran

Open access · goldAbstract readCase Reports
In one paragraph

Article in International journal of surgery case reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Abrar IsmaelDermatology University Hospital, Damascus, Syria; Faculty of Medicine, Damascus University, Damascus, Syria. Electronic address: ismaelabrar1@gmail.com.
Mhd Imadaldin AlsammanFaculty of Medicine, Damascus University, Damascus, Syria. Electronic address: dr.imad1996@gmail.com.
Omar Al LahamFaculty of Medicine, Damascus University, Damascus, Syria. Electronic address: 3omar92@gmail.com.
Reham AlbrijawyFaculty of Medicine, Damascus University, Damascus, Syria. Electronic address: riham.brijawy@gmail.com.
Ayham BadranDermatology University Hospital, Damascus, Syria; Faculty of Medicine, Damascus University, Damascus, Syria. Electronic address: dr.a.badran@hotmail.com.
Damascus University · SY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introduction and importanceAcral Lentiginous Melanoma (ALM) transpires in a profoundly scarce percentage of the population and is intercalated with a low survival rate. This is partly because such tumors are chiefly diagnosed at an advanced stage. Diagnosis is delayed largely due to the difficulties in recognizing the early histopathological signs and clinical presentations of Acral Melanoma. CASE PRESENTATION: We demonstrate the case of a previously healthy 69-year-old Middle Eastern male patient, who presented to our university hospital's Dermatology clinic with a papule under the right ring fingernail with spontaneous Onycholysis of the entire nail, suggesting a spontaneous malformation in his finger. CLINICAL DISCUSSION: ALM is an abundantly rare subtype of melanoma that chiefly originates from the skin of the acral tissues. In this case it arose on the fingernail of a 69-year-old male, who has undergone 2 surgeries to eradicate the tumor with safe margins and as a ramification of successful follow-up for 6 months, has been deemed free of tumor recurrence or metastasis.

conclusionThe aim of this article is to highlight the vitality of early detection, diagnosis, prognosis, and treatment of malignant Acral Lentiginous Melanoma in patients of all ages, especially with older patient populations.

Indexed as

Acral Lentiginous MelanomaCase ReportDermatological MalignancyNodular MelanomaSurgical Oncology

Identifiers

PMID36380543
PMCPMC9468374
OpenAlexW4295183011

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.